In Other News

• New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

• Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

• New Cellular Map May Help Predict Crohn’s Disease Course in Children

• New Cellular Map May Help Predict Crohn’s Disease Course in Children

• Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

• Single-Tube CRISPR Test Detects Pathogens and Genetic Variants in 30 Minutes

• NIH-Funded Study Targets Saliva-Based Long COVID Diagnosis

• Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

• New Journal Addresses Evolving Needs in Clinical and Translational Pathology

• Machine Learning Model Uses Routine Lab Tests to Support Heart Failure Classification

• Validated Biomarker Blood Test Detects Early Lung Cancer and Supports Risk Assessment

• Whole-Blood Extracellular Vesicle Analysis Captures Molecular Signals Missed by Plasma Testing

• Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial

• Temporal Immune Profiling Reveals How Sepsis States Change Over Time

• Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

• Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy

• Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

• Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

• Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency